The activation of OXPHOS pathway and downregulation of BCR signaling observed already at first passages of PDXs might explain their rapid expansion, since MYC-OXPHOS activity has been linked with a proliferative drive in CLL [42, 44, 45]. Here, MYC is linked to B-cell chronic lymphocytic leukemia.